Doctor profile · Federal record

Dr. Vicente Quintero, M.D.

Dermatology Physician (CMS: Dermatology) · New Braunfels, TX

  • NPI 1114978624
  • Accepts Medicare
  • MIPS 76.4 / 100 · 2023
  • 29 yrs in practice
  • Male
  • Solo practice
  • No sanctions

Practice & contact

Operates at 2 locations .

NPPES Updated May 11, 2026
Primary practice
2967 Oak Run Pkwy Ste 210
New Braunfels, TX 781325382
(830) 626-5551
fax (830) 626-5593
Additional location
17331 Ih 35 N Ste 107
Schertz, TX 781541273

Credentials & registration

NPPES · NUCC
NPI registered
May 2006 — 20 yrs on file
Profile last updated
August 26, 2025
Year of graduation
1997 — 29 yrs since
Specialty taxonomy
207N00000X — NUCC code
State license (1)
Texas #L2572
Medicaid
TX #149405601

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1114978624. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
9,458
Distinct HCPCS
10
Medicare allowed
$350,875
HCPCS Description Services Patients Avg allowed
J7345 Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg 4,200 15 $2
17003 Destruction of precancer skin growth, 2-14 growths 1,195 220 $7
99213 Established patient office or other outpatient visit, 20-29 minutes 1,019 712 $88
99214 Established patient office or other outpatient visit, 30-39 minutes 499 334 $125
88305 Pathology examination of tissue using a microscope, intermediate complexity 436 247 $36
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg 417 45 $1
17000 Destruction of precancer skin growth, 1 growth 377 279 $54
17110 Destruction of skin growth, 1-14 growths 267 233 $107
11102 Biopsy of related skin growth, first growth 237 213 $91
99203 New patient office or other outpatient visit, 30-44 minutes 162 162 $109

In context: peer comparison

Among 6 peers in this city , average services per provider: 293. This provider delivers 32× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$2,534
Transactions
104
Manufacturers
15
Payer (manufacturer) Industry Txns Amount
E.R. Squibb & Sons, L.L.C. 13 $358.57
UCB, Inc. 15 $234.68
Amgen Inc. 9 $178.10
Arcutis Biotherapeutics, Inc. 9 $168.98
ABBVIE INC. 8 $157.86
Novartis Pharmaceuticals Corporation 7 $150.74
Janssen Biotech, Inc. 8 $150.38
AstraZeneca Pharmaceuticals LP 3 $146.62
Regeneron Healthcare Solutions, Inc. 5 $121.13
GENZYME CORPORATION 6 $113.52
Lilly USA, LLC 5 $111.55
Mallinckrodt Hospital Products Inc. 5 $104.55
Krystal Biotech Inc 4 $104.43
LEO Pharma Inc. 4 $91.23
Dermavant Sciences, Inc. 3 $65.11

By nature of payment

Food and Beverage
$2,462
Education
$72

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
809
Patients
394
Total drug cost
$23,279
Drug Type Claims Patients Total cost
Triamcinolone Acetonide Generic 160 114 $1,520
Clobetasol Propionate Generic 122 71 $9,692
Minoxidil Generic 93 28 $1,139
Methotrexate (Methotrexate Sodium) Brand 64 12 $1,616
Doxycycline Hyclate Generic 51 16 $1,969
Finasteride Generic 45 15 $341
Imiquimod Generic 45 38 $1,329
Ketoconazole Generic 45 25 $608
Fluconazole Generic 38 25 $447
Doxycycline Monohydrate Generic 35 14 $1,155

Frequently asked questions

Auto-generated from federal data
What is Dr. Vicente Quintero's medical specialty?
Dr. Vicente Quintero practices Dermatology Physician in New Braunfels, TX.
Where does Dr. Vicente Quintero practice?
Dr. Vicente Quintero practices at 2967 Oak Run Pkwy Ste 210, New Braunfels, TX 781325382. Office phone: 8306265551.
What is Dr. Vicente Quintero's NPI?
Dr. Vicente Quintero's National Provider Identifier (NPI) is 1114978624, issued by NPPES.
Does Dr. Vicente Quintero accept Medicare assignment?
Yes. Dr. Vicente Quintero accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Vicente Quintero commonly perform?
Top Medicare-reported procedures in 2023: Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg (HCPCS J7345); Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Established patient office or other outpatient visit (HCPCS 99213). Source: CMS Medicare Physician & Other Practitioners file.